Nitric oxide-cGMP pathway is involved in endotoxin-induced contractile dysfunction in rat hearts
Authors:
- Tetsuya TatsumiTTTetsuya Tatsumi
- Jun AsayamaJAJun Asayama
- Henry FlissHFHenry Fliss
- 1 March 2004
- journal article
- research article
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 96 (3) , 853-860
Abstract
The mechanisms by which endotoxemia causes cardiac depression have not been fully elucidated. The present study examined the involvement of nitric oxide (NO) in this pathology. Rats were infused with lipopolysaccharide (LPS) or saline, and the plasma and myocardial and (NOx) concentrations were measured before or 3, 6, and 24 h after treatment. The hearts were then immediately isolated and mounted in a Langendorff apparatus, and left ventricular developed pressure (LVDP) was determined before biochemical analysis of the myocardium. LPS injection effected the expression of inducible NO synthase (iNOS) in the myocardium, a marked increase in plasma and myocardial NOx levels, and a significant decline in LVDP compared with saline controls. The LPS-induced NO production and concomitant cardiac depression were most pronounced 6 h after LPS injection and were accompanied by a significant increase in myocardial cGMP content. Myocardial ATP levels were not significantly altered after LPS injection. Significant negative correlation was observed between LVDP and myocardial cGMP content, as well as between LVDP and plasma NOx levels. Aminoguanidine, an inhibitor of iNOS, significantly attenuated the LPS-induced NOx production and contractile dysfunction. Furthermore, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, an inhibitor of soluble guanylate cyclase, significantly decreased myocardial cGMP content and attenuated the contractile depression, although aminoguanidine or 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one was not able to completely reverse myocardial dysfunction. Our data suggest that endotoxin-induced contractile dysfunction in rat hearts is associated with NO production by myocardial iNOS and a concomitant increase in myocardial cGMP.Keywords
This publication has 37 references indexed in Scilit:
- MYOCARDIAL DYSFUNCTION IN THE SEPTIC RAT HEARTShock, 1998
- NITRIC OXIDE SYNTHASE IS NOT INVOLVED IN CARDIAC CONTRACTILE DYSFUNCTION IN A RAT MODEL OF ENDOTOXEMIA WITHOUT SHOCKShock, 1997
- Prevention of the Expression of Inducible Nitric Oxide Synthase by Aminoguanidine or Aminoethyl-Isothiourea in Macrophages and in the RatBiochemical and Biophysical Research Communications, 1996
- Characterization of inducible nitric oxide synthase expression in endotoxernic rat cardiac myocytes in vivo and following cytokine exposure in vitroJournal of Molecular and Cellular Cardiology, 1995
- NITRIC OXIDE SYNTHASE INHIBITION DOES NOT PREVENT CARDIAC DEPRESSION IN ENDOTOXIC SHOCKShock, 1995
- Lipopolysaccharide Treatment in Vivo Induces Widespread Tissue Expression of Inducible Nitric Oxide Synthase mRNABiochemical and Biophysical Research Communications, 1993
- Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium.Journal of Clinical Investigation, 1993
- Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric OxideScience, 1992
- Widespread tissue distribution, species distribution and changes in activity of Ca2+‐dependent and Ca2+‐independent nitric oxide synthasesFEBS Letters, 1991
- Myocardial depression during septic shock in humansCritical Care Medicine, 1990